Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2012
Total Assets: $17.15B
Liabilities Breakdown FY2012
Total Liabilities: $10.28B
Asset Breakdown
Total Assets: $17.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $207.0M | 1.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $884.0M | 5.2% |
| Property, Plant & Equipment | $1.56B | 9.1% |
| Goodwill | $5.97B | 34.8% |
| Intangible Assets | $6.29B | 36.7% |
| Other Assets | $2.24B | 13.0% |
Liabilities Breakdown
Total Liabilities: $10.28B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $232.0M | 2.3% |
| Long-Term Debt | $4.20B | 40.8% |
| Other Liabilities | $5.85B | 56.9% |